Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
SPOT ON 100%. ADHC started a new phase. Pennies coming up :))
This is OTC. Nobody is saying that these OTC companies will be the next google or amazon. You trade them when they low and thin. Which is the case of ADHC, low float 330M ONLY, Small OS 595M. Trading low at sub-penny. This is A HUGE OPPORTUNITY to make money.
$ADHC will skyrocket back to penny land. Super thin with a low float. ignore trolls.
Fill my order at 0.0014, I dare you!!! 3M AON.
Super thin. 2M slaps will take this over 0.003
Once volume=100M bid will be@0.0114
Hahaha touché ;)
Let’s go ADHC
Start with yourself and take a hike you POS loser lol!!!
330M float..Super thin. Doesn’t take much to skyrocket this to a penny. A 150M volume should get this over 1 cent. $ADHC is entering a new phase.
Surely undervalued here, huge potential and these prices won’t last long. Naysayers used to say the BRAZOS acquisition is fake news. Well BRAZOS website just confirmed it along with other huge developments.
The Brazos website as well confirms they are part of ADHC. Where is those who were saying Brazos is fake news?
I agree.
Shorts are nervous. They are deeply in trouble and that’s why they didn’t waste anytime to troll. This is going up and the SQUEEZE will get even HARDER.
This is the new ADHC management:
Brazos Biomedical Provides Update on Corporate Overview
Aug 1, 2018
Brazos Biomedical (Brazos) is a privately-held Texas-based limited liability corporation led by Kurt Berens and David Foster, PhD, JD. Mr. Berens and Dr. Foster have more that 45 combined years in developing medical products from devices to therapeutics with particular expertise in development, regulatory and intellectual property strategies. Brazos recently acquired the rights to a suite of intellectual property (IP) including two US patents, PCT and two national phase (AU, CA) applications. The Company also has acquired a prototype device based on the IP that will be used to design, construct and mass produce a market image Class II medical device. In June 2018 American Diversified Holdings Corporation (ADHC) acquired the assets associated with this product. Brazos remains a majority-owned subsidiary of ADHC and Brazos will continue to manage product development.
It’s a new company now. can’t you read the PR. You can clearly see that the BRAZOS unit is the one doing all the business stuff. Great times ahead. There are hundreds on OTC stocks not current, have billions of shares outstanding and tons of debt and they trading higher than this one. This is very undervalued. Just for the OS and float this should be worth 2 cents a share at least.
For sure, 330M float is nothing. OS 598M should be trading above 3 cents.
I agree, notice how that troll is no where to be found lol!!!
News out, nice action today.
As a Holding Company ADCH is uniquely suited to expand into other sectors outside of the Bio-device arena. The cannabis sector has shown some clear market acceptance as evidenced by the recent NASDAQ IPO of Canadian cannabis firm Tilray Inc. The company raised over $153mm and reached $2 billion valuation. Large US based private equity firms are listed as major shareholders of Tilray. Additionally, a GW Parma recently received FDA approval for its pediatric epilepsy drug Epdiolex using cannabis extracts. Along with the current US administration apparent softening of its' stance on federal Cannabis regulation ADHC continues to monitor the cannabis sector seeking opportunities in the sector. Current legislation is pending in congress that will federally legalize cannabis. ADHC has received a proposal from a prominent Cannabis manufacturing company to supply the company with high quality cannabis products for potential pain management therapy. Other acquisition candidates are under review. Management believes the NON-OPIOID pain management markets for Migraine and other chronic pain conditions are highly attractive is todays current environment. ADHC is currently assessing the federal regulatory environment and current medical research protocols to determine if an acquisition in the area is suitable.
ADHC will keep shareholders informed as events progress.
Management has met with medical device engineering firms and have done an exhaustive analysis of the AURACISTM TENS Migraine therapy system including all the patents and patent applications in the US and abroad, patent license agreement, technical engineering schematics, FDA plans, patient study information and other related assets. Current estimates are $2mm to complete all prototype development and FDA compliant market image product development clinical use. Barring any unforeseen issues management believes the $2mm budget should be adequate for all proposed costs over a 24month time frame. Brazos Biomedical is currently meeting with institutional investors to devise a financing strategy to successfully bring The AURACIS product to market.
Investors can find a complete overview of all the AURACIS information on the www.BrazosBiomedical.com website.
ADHC is Also Targeting Additional Acquisition Candidates In the Cannabis Sector Based Upon Recent Forbes estimates that the Global Cannabis Industry Could Exceed $30 Billion
American Diversified Holdings Corporation Completes Cost Projection "USE OF FUNDS" to Develop the Brazos Biomedical Non-Opioid AURACISTM "Tens" Migraine Management System
Projected Cost of $2mm to Complete Auracis Tens Migraine Therapy through Engineering Development to FDA Approval Over 2year Time Frame
ADHC is super thin.
Great NEWS!!!!
I agree, I have been trading ADHC for almost 2 years now. It has been an ATM. I love the low float and share structure here. A lot of have changed to the best and while at times the share price might look ugly, I always take it as an opportunity to buy low and average down. It worked every single time. Keep calm & believe :)
When volume comes you won’t be able to get your hand at any shares below 0.001. This is a strong buy and hold. It will explode soon in my opinion. Patience will pay off :))
Today’s action has nothing to do with Tony. The market always knows ahead of time. I have seen so many tickers like this struggle for a while and then KABOOM!!! A multi day run. I strongly believe this one has strong legs to go much much higher than 0.002
If News hits, USEI could see 0.005+
0.0008 coming up, teens to follow :))
USEI
USEI looking good, teens coming :))
It went last April from 0.001 to 0.012. Now the float is 330M vs 420M and the OS is 100M less than back then to about 590M. Now we have Brazos acquizition completed and we have debt reduced by more than $1M. Please tell me why would this run to over 0.012 given these stats and FACTS?
$ADHC
Yep, looks like this could burst into teens this week. I can’t wait for tomorrow :))
Mostly panic sells due. I am sure shorts are delighted to ignite that and cover their short position. Very smart move.
I agree with you. I hope it will stay below 0.002 for a little bit so I can clear as much powder as I can so I can load the crap out of this low floater. From the last PRs we know that float hasn’t changed and still at 330M and the OS is sitting at 597M I believe and that’s very very low. This is destined for a run to penny land.
wow damson I missed this this. The question is how much I will be up when this goes to pennies.
Hahahaha I had bids at 0.0001 for over a year and never got 1 share. I had to slap the ask at 0.0002 and I am happy. Soon trips will be a thing of the past :)
0.001+ tomorrow imo, this action is telling ;)
Teens are written all over this. Should be a nice few days ahead :)
FERN looks ready to POP. Teens coming :)